INHIBITION OF SKIN DEVELOPMENT BY OVEREXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA-1 IN THE EPIDERMIS OF TRANSGENIC MICE

被引:230
作者
SELLHEYER, K
BICKENBACH, JR
ROTHNAGEL, JA
BUNDMAN, D
LONGLEY, MA
KRIEG, T
ROCHE, NS
ROBERTS, AB
ROOP, DR
机构
[1] BAYLOR COLL MED, DEPT CELL BIOL, HOUSTON, TX 77030 USA
[2] BAYLOR COLL MED, DEPT DERMATOL, HOUSTON, TX 77030 USA
[3] UNIV COLOGNE, DEPT DERMATOL, W-5000 COLOGNE 41, GERMANY
[4] NCI, CHEMOPREVENT LAB, BETHESDA, MD 20892 USA
关键词
KERATINOCYTES; GROWTH FACTORS; MITOTIC ARREST; LETHALITY;
D O I
10.1073/pnas.90.11.5237
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
To assess the effect of transforming growth factor beta1 on the skin in vivo, we have targeted its expression to the epidermis of transgenic mice. To ensure that active TGF-beta1 was expressed, we used a porcine TGF-beta1 cDNA with mutations of Cys-223 --> Ser and Cys-225 --> Ser, which allow constitutive activation. Mice expressing the mutant transforming growth factor beta1 transgene exhibited a marked phenotype at birth. The skin was very shiny and tautly stretched. These animals were rigid and appeared to be restricted in their ability to move and breathe; death occurred within 24 hr. Histologically, the most prominent features of the skin were a compact orthohyperkeratosis and a reduction in the number of hair follicles. Pulse-labeling studies with 5-bromodeoxyuridine demonstrated a marked reduction in the number of replicating cells in the epidermis and hair follicles. Thus, the macro- and microscopic appearance of these mice, as well as their neonatal lethality, most likely result from inhibition of normal skin development and suppression of epithelial cell proliferation by the overexpression of transforming growth factor beta1.
引用
收藏
页码:5237 / 5241
页数:5
相关论文
共 30 条
[1]  
BRUNNER AM, 1989, J BIOL CHEM, V264, P13660
[2]  
COFFEY RJ, 1988, CANCER RES, V48, P1596
[3]   IMPROVED SANDWICH ENZYME-LINKED IMMUNOSORBENT ASSAYS FOR TRANSFORMING GROWTH FACTOR-BETA-1 [J].
DANIELPOUR, D .
JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 158 (01) :17-25
[4]  
DAVIDSON P, 1952, J ANAT, V86, P342
[5]   TRANSFORMING GROWTH FACTOR-BETA-1 - HISTOCHEMICAL-LOCALIZATION WITH ANTIBODIES TO DIFFERENT EPITOPES [J].
FLANDERS, KC ;
THOMPSON, NL ;
CISSEL, DS ;
VANOBBERGHENSCHILLING, E ;
BAKER, CC ;
KASS, ME ;
ELLINGSWORTH, LR ;
ROBERTS, AB ;
SPORN, MB .
JOURNAL OF CELL BIOLOGY, 1989, 108 (02) :653-660
[6]   INDUCTION OF EPIDERMAL HYPERPLASIA, HYPERKERATOSIS, AND PAPILLOMAS IN TRANSGENIC MICE BY A TARGETED V-HA-RAS ONCOGENE [J].
GREENHALGH, DA ;
ROTHNAGEL, JA ;
QUINTANILLA, MI ;
ORENGO, CC ;
GAGNE, TA ;
BUNDMAN, DS ;
LONGLEY, MA ;
ROOP, DR .
MOLECULAR CARCINOGENESIS, 1993, 7 (02) :99-110
[7]  
GREENHALGH DA, 1993, IN PRESS ONCOGENE
[8]  
JUTLEY JK, 1991, J INVEST DERMATOL, V96, P1004
[9]  
KIM SJ, 1992, J BIOL CHEM, V267, P13702
[10]   TRANSFORMING GROWTH FACTOR-BETA-1 NULL MUTATION IN MICE CAUSES EXCESSIVE INFLAMMATORY RESPONSE AND EARLY DEATH [J].
KULKARNI, AB ;
HUH, CG ;
BECKER, D ;
GEISER, A ;
LYGHT, M ;
FLANDERS, KC ;
ROBERTS, AB ;
SPORN, MB ;
WARD, JM ;
KARLSSON, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) :770-774